1. Collins, F. S., Green, E. D., Guttmacher, A. E., Guyer, M. S. & US National Human Genome Research Institute. A vision for the future of genomics research. Nature 422, 835–847 (2003).
2. Hopkins, M. M. et al. Putting pharmacogenetics into practice. Nature Biotechnol. 24, 403–410 (2006).
3. Holm, S. in The Power of Pills: Social, Ethical and Legal Issues in Drug Development, Marketing and Pricing (eds Cohen, J. C., Illingworth, P. & Schuklenk, U.) 98–109 (Pluto, Ann Arbor, Michigan, 2006).
4. Seguin, B., Essajee, S., Jimenez-Sanchez, G., Singer, P. A. & Daar, A. S. in Pharmacogenomics in Admixed Populations (ed. Suarez-Kurtz, G.) 198–207 (Landes Bioscience, Austin, Texas, 2007).
5. Boulyjenkov, V. & Schapper, C. (eds) The ethical, legal and social implications of pharmacogenomics in developing countries: report of an international group of experts. World Health Organization (Earthscan, London, 2007).